[Federal Register Volume 62, Number 215 (Thursday, November 6, 1997)]
[Notices]
[Page 60096]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-29364]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Meeting

    Pursuant to Section 10(a) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of 
the National Cancer Institute (NCI) Board of Scientific Advisors on 
November 13-14, 1997 in Conference Room 10, Building 31C, National 
Institutes of Health, 9000 Rockville Pike, Bethesda, Maryland.
    This meeting will be open on November 13 from 8 a.m. to recess and 
on November 14 from 8:00 a.m. to adjournment. Agenda items will include 
the following: NCI Director's Report; Deputy Director of Extramural 
Science's Reports; Legislative Update; Scientific Presentation(s); 
Concept Reviews; program review updates and reports, and discussions 
pertaining to new and ongoing Board business. Attendance by the public 
will be limited to space available.
    Individuals who plan to attend and need special assistance such as 
sign language interpretation or other reasonable accommodations and 
additional information pertaining to the meeting should contact Dr. 
Paulette S. Gray, Executive Secretary, NCI Board of Scientific 
Advisors, 6130 Executive Blvd., EPN, Rm. 600C, Bethesda, MD 20892 (301-
496-4218).
    This notice is being published less than 15 days prior to the 
meeting due to the urgent need to meet timing limitations imposed by 
the review and funding cycle.

    Dated: October 30, 1997.
LaVerne Y. Stringfield,
Committee Management Officer, NIH.
[FR Doc. 97-29364 Filed 11-5-97; 8:45 am]
BILLING CODE 4140-01-M